Jacobio Pharmaceuticals Group Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-168.00
-396.00
-432.00
-362.00
-1,700.00
-482.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
83.00
-14.00
153.00
130.00
-180.00
3.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-42.00
-380.00
-342.00
-177.00
87.00
-125.00
Cash Flow from Investing Activities
232.00
-89.00
-792.00
205.00
-247.00
-14.00
Cash Flow from Financing Activities
30.00
275.00
-8.00
132.00
1,441.00
12.00
Net Cash Inflow / Outflow
225.00
-183.00
-1,044.00
127.00
1,255.00
-120.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.00
11.00
99.00
-31.00
-25.00
6.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Jacobio Pharmaceuticals Group Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-168.823410292516
-395.13020026853
227.00
57.27%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
83.5654684371834
-125.133526335466
208.00
166.78%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-42.2142553079086
-251.747018215956
209.00
83.23%
Cash Flow from Investing Activities
232.523729487334
4.29569486401979
228.00
5312.95%
Cash Flow from Financing Activities
30.2053920283298
-293.177379685902
323.00
110.30%
Net Cash Inflow / Outflow
225.450253138835
-531.179692250374
756.00
142.44%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4.93538693107998
9.44901078746402
-5.00
-47.77%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 88.92% vs -11.14% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-42.21
-380.85
88.92%






